学术探索
学术期刊
新闻热点
数据分析
智能评审

Up-regulation of a serine-threonine kinase protooncogene Pim-1 in oral squamous cell carcinoma

被引：38
作者：
Chiang, W. -F.
Yen, C. -Y.
Lin, C. -N.
Liaw, G. -A.
Chiu, C. -T.
Hsia, Y. -J.
Liu, S. -Y. [1 ]
机构：
[1] Chi Mei Med Ctr, Dept Oral & Maxillofacial Surg, Tainan, Taiwan
[2] Chi Mei Hosp, Dept Oral & Maxillofacial Surg, Liouying, Taiwan
[3] Taipei Med Univ, Coll Oral Med, Dept Dent, Taipei, Taiwan
[4] Natl Def Med Ctr, Sch Dent, Taipei, Taiwan
[5] Chang Gung Mem Hosp, Dept Oral & Maxillofacial Surg, Kaohsiung, Taiwan
来源：
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY | 2006年 / 35卷 / 08期
关键词：
oral cancer; Pim-1;
D O I：
10.1016/j.ijom.2006.01.027
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The Pim-1 proto-oncogene, encoding a serine-threonine kinase, has been found to play an important role in regulating apoptosis, differentiation, proliferation and tumourigenesis. The present study was conducted to assess the importance of Pim-1 in oral tumourigenesis in vivo. Reverse transcriptase-polymerase chain reaction and immunohistochemistry were used to study the expression of Pim-1 in oral squamous cell carcinoma (OSCC) and non-cancerous match tissue (NCMT) sampled from the periphery of the tumours. Pim-1 mRNA expression in OSCC was significantly higher than that in NCMT in 36 tissue pairs (1.33 +/- 0.41 versus 0.97 +/- 0.29, P = 0.03). The percentage of OSCCs exhibiting strong cytoplasmic Pim-1 immunoreactivity was significantly higher than that of NCMT (60% versus 19%, P = 0.007). Pim-1 immunoreactivity is higher in the more differentiated components of a tumour. In around 10% of OSCC cases, Pim-1 immunoreactivity was found in the nucleus as well. These results show novel findings of the upregulation of Pim-1 expression from NCMT to OSCC. The pathogenetic role of Pim-1 expression in oral tumourigenesis deserves further investigation.
引用
收藏
页码：740 / 745
页数：6
相关论文
共 16 条
[1]   Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site [J].
Aho, TLT ;
Sandholm, J ;
Peltola, KJ ;
Mankonen, HP ;
Lilly, M ;
Koskinen, PJ .
FEBS LETTERS, 2004, 571 (1-3) :43-49
[2]  
BERNS A, 1989, INT J CANCER, P22
[3]   p53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis [J].
Chang, KW ;
Sarraj, S ;
Lin, SC ;
Tsai, PI ;
Solt, D .
CARCINOGENESIS, 2000, 21 (07) :1441-1451
[4]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[5]   Myc-driven murine prostate cancer shares molecular features with human prostate tumors [J].
Ellwood-Yen, K ;
Graeber, TG ;
Wongvipat, J ;
Iruela-Arispe, ML ;
Zhang, JF ;
Matusik, R ;
Thomas, GV ;
Sawyers, CL .
CANCER CELL, 2003, 4 (03) :223-238
[6]  
Ionov Y, 2003, ANTICANCER RES, V23, P167
[7]   Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002 [J].
Jacobs, MD ;
Black, J ;
Futer, O ;
Swenson, L ;
Hare, B ;
Fleming, M ;
Saxena, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (14) :13728-13734
[8]   Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma [J].
Liu, SY ;
Yen, CY ;
Yang, SC ;
Chiang, WF ;
Chang, KW .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (06) :702-707
[9]   Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: Factors affecting survival [J].
Lo, WL ;
Kao, SY ;
Chi, LY ;
Wong, YK ;
Chang, RCS .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 61 (07) :751-758
[10]  
Roh M, 2003, CANCER RES, V63, P8079
12